Search research articles
Contact Us
Filters
Showing results (61-70 of 148) with videos related to
Page
of 15
Sort By:
Mayo Clinic Proceedings
|
August 6, 2019
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
Aref Al-Kali, Darci Zblewski, James M Foran, et al.
Blood Cancer Journal
|
February 23, 2022
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)
Youssef Salama, Fang Zhao, Jennifer L Oliveira, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 20, 2016
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia
Mehrdad Hefazi, Moussab Damlaj, Hassan B Alkhateeb, et al.
Annals of Hematology
|
March 28, 2025
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome
Guillermo Garcia-Manero, Manila Gaddh, Uwe Platzbecker, et al.
American Journal of Hematology
|
March 21, 2013
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome
Aref Al-Kali, Alfonso Quintás-Cardama, Raja Luthra, et al.
European Journal of Haematology
|
October 26, 2011
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy
Michelle A Elliott, Louis Letendre, Ayalew Tefferi, et al.
JAMA Oncology
|
February 3, 2017
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia
Natalie Ertz-Archambault, Heidi Kosiorek, Gretchen E Taylor, et al.
Haematologica
|
October 30, 2025
Patient-centered care strategies for Jehovah's Witnesses with acute leukemia and high-grade myeloid neoplasms
Jabra Zarka, Aref Al-Kali, Hassan B Alkhateeb, et al.
Leukemia Research
|
June 7, 2025
Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms
Yazan Jabban, Rong He, Kurt Bessonen, et al.
Haematologica
|
February 27, 2025
Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia following Venetoclax plus Hypomethylating Agent Therapy
Isla M Johnson, Rimal Ilyas, Kristen McCullough, et al.
Page
of 15
Search research articles
Search
Showing results (61-70 of 148) with videos related to
Sort By:
Page
of 15
Mayo Clinic Proceedings
|
August 6, 2019
Outcome of Myelodysplastic Syndromes Over Time in the United States: A National Cancer Data Base Study From 2004-2013
Aref Al-Kali, Darci Zblewski, James M Foran, et al.
Blood Cancer Journal
|
February 23, 2022
Isolated anemia in patients with large granular lymphocytic leukemia (LGLL)
Youssef Salama, Fang Zhao, Jennifer L Oliveira, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
September 20, 2016
Vancomycin-resistant Enterococcus colonization and bloodstream infection: prevalence, risk factors, and the impact on early outcomes after allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia
Mehrdad Hefazi, Moussab Damlaj, Hassan B Alkhateeb, et al.
Annals of Hematology
|
March 28, 2025
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome
Guillermo Garcia-Manero, Manila Gaddh, Uwe Platzbecker, et al.
American Journal of Hematology
|
March 21, 2013
Prognostic impact of RAS mutations in patients with myelodysplastic syndrome
Aref Al-Kali, Alfonso Quintás-Cardama, Raja Luthra, et al.
European Journal of Haematology
|
October 26, 2011
Therapy-related acute promyelocytic leukemia: observations relating to APL pathogenesis and therapy
Michelle A Elliott, Louis Letendre, Ayalew Tefferi, et al.
JAMA Oncology
|
February 3, 2017
Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia
Natalie Ertz-Archambault, Heidi Kosiorek, Gretchen E Taylor, et al.
Haematologica
|
October 30, 2025
Patient-centered care strategies for Jehovah's Witnesses with acute leukemia and high-grade myeloid neoplasms
Jabra Zarka, Aref Al-Kali, Hassan B Alkhateeb, et al.
Leukemia Research
|
June 7, 2025
Clinical characteristics and prognostic significance of co-mutated SETBP1/GATA2 myeloid neoplasms
Yazan Jabban, Rong He, Kurt Bessonen, et al.
Haematologica
|
February 27, 2025
Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia following Venetoclax plus Hypomethylating Agent Therapy
Isla M Johnson, Rimal Ilyas, Kristen McCullough, et al.
Page
of 15